Cancer Research 2010 AACR Elections Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aqeilan, R. I.
Right arrow Articles by Croce, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aqeilan, R. I.
Right arrow Articles by Croce, C. M.
[Cancer Research 65, 6764-6772, August 1, 2005]
© 2005 American Association for Cancer Research

Cell and Tumor Biology

WW Domain–Containing Proteins, WWOX and YAP, Compete for Interaction with ErbB-4 and Modulate Its Transcriptional Function

Rami I. Aqeilan1, Valentina Donati1, Alexey Palamarchuk1, Francesco Trapasso1, Mohamed Kaou1, Yuri Pekarsky1, Marius Sudol2,3 and Carlo M. Croce1

1 Human Cancer Genetics Program, Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio; 2 Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania; and 3 Department of Medicine, Mt. Sinai School of Medicine, New York, New York

Requests for reprints: Rami I. Aqeilan, Department of Human Cancer Genomics, The Ohio State University, Room 455E, Wiseman Hall, 410 West 12th Avenue, Columbus, OH 43220. Phone: 614-292-3120; Fax: 614-292-4053; E-mail: rami.aqeilan{at}osumc.edu.

The WW domain–containing oxidoreductase, WWOX, is a tumor suppressor that is deleted or altered in several cancer types. We recently showed that WWOX interacts with p73 and AP-2{gamma} and suppresses their transcriptional activity. Yes-associated protein (YAP), also containing WW domains, was shown to associate with p73 and enhance its transcriptional activity. In addition, YAP interacts with ErbB-4 receptor tyrosine kinase and acts as transcriptional coactivator of the COOH-terminal fragment (CTF) of ErbB-4. Stimulation of ErbB-4–expressing cells with 12-O-tetradecanoylphorbol-13-acetate (TPA) results in the proteolytic cleavage of its cytoplasmic domain and translocation of this domain to the nucleus. Here we report that WWOX physically associates with the full-length ErbB-4 via its first WW domain. Coexpression of WWOX and ErbB-4 in HeLa cells followed by treatment with TPA results in the retention of ErbB-4 in the cytoplasm. Moreover, in MCF-7 breast carcinoma cells, expressing high levels of endogenous WWOX, endogenous ErbB-4 is also retained in the cytoplasm. In addition, our results show that interaction of WWOX and ErbB-4 suppresses transcriptional coactivation of CTF by YAP in a dose-dependent manner. A mutant form of WWOX lacking interaction with ErbB-4 has no effect on this coactivation of ErbB-4. Furthermore, WWOX is able to inhibit coactivation of p73 by YAP. In summary, our data indicate that WWOX antagonizes the function of YAP by competing for interaction with ErbB-4 and other targets and thus affect its transcriptional activity.




This article has been cited by other articles:


Home page
 Mol. Cell. Biol.Home page
R. S. Muraoka-Cook, M. A. Sandahl, K. E. Strunk, L. C. Miraglia, C. Husted, D. M. Hunter, K. Elenius, L. A. Chodosh, and H. S. Earp III
ErbB4 Splice Variants Cyt1 and Cyt2 Differ by 16 Amino Acids and Exert Opposing Effects on the Mammary Epithelium In Vivo
Mol. Cell. Biol., September 15, 2009; 29(18): 4935 - 4948.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L.-J. Hsu, L. Schultz, Q. Hong, K. Van Moer, J. Heath, M.-Y. Li, F.-J. Lai, S.-R. Lin, M.-H. Lee, C.-P. Lo, et al.
Transforming Growth Factor {beta}1 Signaling via Interaction with Cell Surface Hyal-2 and Recruitment of WWOX/WOX1
J. Biol. Chem., June 5, 2009; 284(23): 16049 - 16059.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
E. Matteucci, P. Bendinelli, and M. A. Desiderio
Nuclear localization of active HGF receptor Met in aggressive MDA-MB231 breast carcinoma cells
Carcinogenesis, June 1, 2009; 30(6): 937 - 945.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
F. Zeng, J. Xu, and R. C. Harris
Nedd4 mediates ErbB4 JM-a/CYT-1 ICD ubiquitination and degradation in MDCK II cells
FASEB J, June 1, 2009; 23(6): 1935 - 1945.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. I. Aqeilan, J. P. Hagan, A. de Bruin, M. Rawahneh, Z. Salah, E. Gaudio, H. Siddiqui, S. Volinia, H. Alder, J. B. Lian, et al.
Targeted Ablation of the WW Domain-Containing Oxidoreductase Tumor Suppressor Leads to Impaired Steroidogenesis
Endocrinology, March 1, 2009; 150(3): 1530 - 1535.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
S.-M. Feng, R. S. Muraoka-Cook, D. Hunter, M. A. Sandahl, L. S. Caskey, K. Miyazawa, A. Atfi, and H. S. Earp III
The E3 Ubiquitin Ligase WWP1 Selectively Targets HER4 and Its Proteolytically Derived Signaling Isoforms for Degradation
Mol. Cell. Biol., February 1, 2009; 29(3): 892 - 906.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
T. Yokoyama, H. Osada, H. Murakami, Y. Tatematsu, T. Taniguchi, Y. Kondo, Y. Yatabe, Y. Hasegawa, K. Shimokata, Y. Horio, et al.
YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation
Carcinogenesis, November 1, 2008; 29(11): 2139 - 2146.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Kawahara, T. Hori, K. Chonabayashi, T. Oka, M. Sudol, and T. Uchiyama
Kpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73
Blood, November 1, 2008; 112(9): 3856 - 3866.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. I. Aqeilan, M. Q. Hassan, A. de Bruin, J. P. Hagan, S. Volinia, T. Palumbo, S. Hussain, S.-H. Lee, T. Gaur, G. S. Stein, et al.
The WWOX Tumor Suppressor Is Essential for Postnatal Survival and Normal Bone Metabolism
J. Biol. Chem., August 1, 2008; 283(31): 21629 - 21639.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
C.-P. Chuu, R.-Y. Chen, J. L. Barkinge, M. F. Ciaccio, and R. B. Jones
Systems-Level Analysis of ErbB4 Signaling in Breast Cancer: A Laboratory to Clinical Perspective
Mol. Cancer Res., June 1, 2008; 6(6): 885 - 891.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Sundvall, A. Korhonen, I. Paatero, E. Gaudio, G. Melino, C. M. Croce, R. I. Aqeilan, and K. Elenius
Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoforms
PNAS, March 18, 2008; 105(11): 4162 - 4167.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. Guler, D. Iliopoulos, N. Guler, C. Himmetoglu, M. Hayran, and K. Huebner
Wwox and Ap2{gamma} Expression Levels Predict Tamoxifen Response
Clin. Cancer Res., October 15, 2007; 13(20): 6115 - 6121.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. I. Aqeilan, V. Donati, E. Gaudio, M. S. Nicoloso, M. Sundvall, A. Korhonen, J. Lundin, J. Isola, M. Sudol, H. Joensuu, et al.
Association of Wwox with ErbB4 in Breast Cancer
Cancer Res., October 1, 2007; 67(19): 9330 - 9336.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
J. Omerovic, L. Santangelo, E. M.-R. Puggioni, J. Marrocco, C. Dall'Armi, C. Palumbo, F. Belleudi, L. Di Marcotullio, L. Frati, M.-R. Torrisi, et al.
The E3 ligase Aip4/Itch ubiquitinates and targets ErbB-4 for degradation
FASEB J, September 1, 2007; 21(11): 2849 - 2862.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
H. R. Qin, D. Iliopoulos, T. Nakamura, S. Costinean, S. Volinia, T. Druck, J. Sun, H. Okumura, and K. Huebner
Wwox Suppresses Prostate Cancer Cell Growth through Modulation of ErbB2-Mediated Androgen Receptor Signaling
Mol. Cancer Res., September 1, 2007; 5(9): 957 - 965.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Oberst, M. Malatesta, R. I. Aqeilan, M. Rossi, P. Salomoni, R. Murillas, P. Sharma, M. R. Kuehn, M. Oren, C. M. Croce, et al.
The Nedd4-binding partner 1 (N4BP1) protein is an inhibitor of the E3 ligase Itch
PNAS, July 3, 2007; 104(27): 11280 - 11285.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. I. Aqeilan, F. Trapasso, S. Hussain, S. Costinean, D. Marshall, Y. Pekarsky, J. P. Hagan, N. Zanesi, M. Kaou, G. S. Stein, et al.
Targeted deletion of Wwox reveals a tumor suppressor function
PNAS, March 6, 2007; 104(10): 3949 - 3954.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
V. Donati, G. Fontanini, M. Dell'Omodarme, M. C. Prati, S. Nuti, M. Lucchi, A. Mussi, M. Fabbri, F. Basolo, C. M. Croce, et al.
WWOX Expression in Different Histologic Types and Subtypes of Non-Small Cell Lung Cancer
Clin. Cancer Res., February 1, 2007; 13(3): 884 - 891.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. Iliopoulos, M. Fabbri, T. Druck, H. R. Qin, S.-Y. Han, and K. Huebner
Inhibition of Breast Cancer Cell Growth In vitro and In vivo: Effect of Restoration of Wwox Expression
Clin. Cancer Res., January 1, 2007; 13(1): 268 - 274.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Gaudio, A. Palamarchuk, T. Palumbo, F. Trapasso, Y. Pekarsky, C. M. Croce, and R. I. Aqeilan
Physical Association with WWOX Suppresses c-Jun Transcriptional Activity
Cancer Res., December 15, 2006; 66(24): 11585 - 11589.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Linggi and G. Carpenter
ErbB-4 s80 Intracellular Domain Abrogates ETO2-dependent Transcriptional Repression
J. Biol. Chem., September 1, 2006; 281(35): 25373 - 25380.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N.-S. Chang, J. Doherty, A. Ensign, L. Schultz, L.-J. Hsu, and Q. Hong
WOX1 Is Essential for Tumor Necrosis Factor-, UV Light-, Staurosporine-, and p53-mediated Cell Death, and Its Tyrosine 33-phosphorylated Form Binds and Stabilizes Serine 46-phosphorylated p53
J. Biol. Chem., December 30, 2005; 280(52): 43100 - 43108.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Fabbri, D. Iliopoulos, F. Trapasso, R. I. Aqeilan, A. Cimmino, N. Zanesi, S. Yendamuri, S.-Y. Han, D. Amadori, K. Huebner, et al.
WWOX gene restoration prevents lung cancer growth in vitro and in vivo
PNAS, October 25, 2005; 102(43): 15611 - 15616.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.